Ashley E. Ross MD, PhDAssociate Professor of Urology, Northwestern Medicine, Feinberg School of Medicine, Chicago, Ilinois
Dr. Ross is a surgeon scientist who specializes in urology and urologic oncology and is a nationally recognized expert in prostate cancer. His research efforts focus on the development, testing and implementation of novel diagnostics and therapeutics with a goal of reducing the suffering from prostate cancer. Clinically, Dr. Ross performs prostate cancer screening, prostate biopsy (including MRI-fusion biopsy), active surveillance, robotic prostatectomy, open radical prostatectomy, and ablative therapies of the prostate. Prior to joining the Feinberg School of Medicine, Dr. Ross served as director of the Johns Hopkins Urology Prostate Cancer Program, the executive medical director of the Mary Crowley Cancer Research Center, and an associate chair of the US Oncology Genitourinary Research Committee.
Dr. Ross is a consultant for GenomeDX which produces the Decipher test.
Recent Contributions to PracticeUpdate:
- An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer
- The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-Volume Metastatic Prostate Cancer
- Comparison of Prostate Health Index, Total PSA, %free PSA, and ProPSA
- 17-Gene Genomic Prostate Score Test Results in Active Surveillance Cohort
- Increased Frequency of Germline BRCA2 Mutations in Prostate Cancer Metastasis in a Racially Diverse Patient Population
- Prostate Cancer Germline Genetics in Clinical Practice
- Utility of the Genomic Prostate Score in Men With Very Low– to Intermediate-Risk Prostate Cancer
- Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy
- Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity
- Prostate Genetic Score and Risk of Prostate Cancer